HPS2-THRIVE: Niacin Fails to Show Benefit in Patients at High Risk of Vascular Events

Article Information

DOI 
http://dx.doi.org/10.1177/155989771302005
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Phil Vinall
  1. Jane Armitage, MD
    1. Oxford Clinical Trial Service, Oxford University, Oxford, United Kingdom
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
Jun 2015100
Jul 2015611
Aug 2015100
Sep 2015200
Oct 2015333
Total1844

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
HPS2-THRIVE: Niacin Fails to Show Benefit in Patients at High Risk of Vascular Events
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cardiology Clinical Trials
Lipid Disorders
Cardiology & Cardiovascular Medicine
Cardiology Clinical Trials
Lipid Disorders